Related Experiment Video
Updated: Oct 24, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Use of Chimeric Antigen Receptor Modified T Cells With Extensive Leukemic Myocardial Involvement
Brian Han1, Raul Montiel-Esparza2, Henry Chubb1
1Department of Pediatrics, Division of Cardiology, Lucile Packard Children's Hospital at Stanford, Stanford University Medical Center, Palo Alto, California, USA.
No abstract available in PubMed .
More Related Videos
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Targeted Cancer Therapies
There are several types of targeted therapies against...